Nothing Special   »   [go: up one dir, main page]

DK136157C - - Google Patents

Info

Publication number
DK136157C
DK136157C DK328673A DK328673A DK136157C DK 136157 C DK136157 C DK 136157C DK 328673 A DK328673 A DK 328673A DK 328673 A DK328673 A DK 328673A DK 136157 C DK136157 C DK 136157C
Authority
DK
Denmark
Application number
DK328673A
Other languages
Danish (da)
Other versions
DK136157B (en
Inventor
G H Phillipps
C E Newall
Original Assignee
Glaxo Laboratories Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Laboratories Ltd filed Critical Glaxo Laboratories Ltd
Publication of DK136157B publication Critical patent/DK136157B/en
Application granted granted Critical
Publication of DK136157C publication Critical patent/DK136157C/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J41/00Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Steroid Compounds (AREA)
DK328673AA 1972-06-15 1973-06-14 Analogous process for the preparation of 3alpha-hydroxy-17beta-carboxylic acid derivatives of the androstane series or salts thereof. DK136157B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB2811872A GB1434919A (en) 1972-06-15 1972-06-15 3alpha-hydroxy androstanes

Publications (2)

Publication Number Publication Date
DK136157B DK136157B (en) 1977-08-22
DK136157C true DK136157C (en) 1978-01-23

Family

ID=10270562

Family Applications (1)

Application Number Title Priority Date Filing Date
DK328673AA DK136157B (en) 1972-06-15 1973-06-14 Analogous process for the preparation of 3alpha-hydroxy-17beta-carboxylic acid derivatives of the androstane series or salts thereof.

Country Status (9)

Country Link
BE (1) BE800899R (en)
CA (1) CA1040619A (en)
DE (1) DE2330342A1 (en)
DK (1) DK136157B (en)
FR (1) FR2189034B2 (en)
GB (1) GB1434919A (en)
LU (1) LU67790A1 (en)
NL (1) NL7308267A (en)
ZA (1) ZA734037B (en)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG10201802389SA (en) 2013-04-17 2018-04-27 Sage Therapeutics Inc 19-nor c3,3-disubstituted c21-n-pyrazolyl steroids and methods of use thereof
LT2986624T (en) 2013-04-17 2020-07-10 Sage Therapeutics, Inc. 19-nor neuroactive steroids for methods of treatment
WO2014169836A1 (en) 2013-04-17 2014-10-23 Sage Therapeutics, Inc. 19-nor neuroactive steroids and methods of use thereof
US9725481B2 (en) 2013-04-17 2017-08-08 Sage Therapeutics, Inc. 19-nor C3, 3-disubstituted C21-C-bound heteroaryl steroids and methods of use thereof
DK3021852T3 (en) * 2013-07-19 2021-03-15 Sage Therapeutics Inc NEUROACTIVE STEROIDS, COMPOSITIONS AND USES
ES2848823T3 (en) 2013-08-23 2021-08-12 Sage Therapeutics Inc Neuroactive steroids, compositions and uses thereof
US10246482B2 (en) 2014-06-18 2019-04-02 Sage Therapeutics, Inc. Neuroactive steroids, compositions, and uses thereof
AU2015331749A1 (en) 2014-10-16 2017-05-04 Sage Therapeutics, Inc. Compositions and methods for treating CNS disorders
HUE051488T2 (en) 2014-10-16 2021-03-01 Sage Therapeutics Inc Compositions and methods for treating cns disorders
US10774108B2 (en) 2014-11-27 2020-09-15 Sage Therapeutics, Inc. Compositions and methods for treating CNS disorders
RS61530B1 (en) 2015-01-26 2021-04-29 Sage Therapeutics Inc Compositions and methods for treating cns disorders
US10329320B2 (en) 2015-02-20 2019-06-25 Sage Therapeutics, Inc. Neuroactive steroids, compositions, and uses thereof
DK3481844T3 (en) 2016-07-11 2024-07-22 Sage Therapeutics Inc C7, C12 and C16 substituted neuroactive steroids and their methods of use
EP3481845B1 (en) 2016-07-11 2023-09-13 Sage Therapeutics, Inc. C17, c20, and c21 substituted neuroactive steroids and their methods of use
KR20220016098A (en) 2019-05-31 2022-02-08 세이지 테라퓨틱스, 인크. Neuroactive steroids and compositions thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH273860A (en) * 1942-04-25 1951-02-28 Nv Organon Process for the preparation of a compound of the cyclopentanopolyhydrophenanthrene series which contains an oxygen-containing group in ring C.
GB1380246A (en) * 1970-12-17 1975-01-08 Glaxo Lab Ltd 3alpha-hydroxy-androstanes and esters thereof
IL38376A (en) * 1970-12-17 1977-07-31 Glaxo Lab Ltd 3alpha-hydroxy-steroids of the androstane and pregnane series their preparation and pharmaceutical compositions containing them

Also Published As

Publication number Publication date
CA1040619A (en) 1978-10-17
LU67790A1 (en) 1973-08-16
ZA734037B (en) 1974-05-29
FR2189034B2 (en) 1977-01-21
NL7308267A (en) 1973-12-18
DK136157B (en) 1977-08-22
AU5693773A (en) 1974-12-19
DE2330342A1 (en) 1974-01-17
FR2189034A2 (en) 1974-01-25
GB1434919A (en) 1976-05-12
BE800899R (en) 1973-12-14

Similar Documents

Publication Publication Date Title
JPS49133191A (en)
FR2189034B2 (en)
JPS5312015Y2 (en)
FR2197673B1 (en)
JPS5023861B2 (en)
JPS4933275U (en)
JPS4910557A (en)
JPS4945913A (en)
JPS49100562A (en)
JPS5210270Y2 (en)
JPS4970150A (en)
JPS4940655U (en)
JPS5252842Y2 (en)
JPS4887233U (en)
JPS4885082A (en)
JPS4921267A (en)
JPS4915626U (en)
JPS4932566U (en)
JPS49104123U (en)
JPS48110196U (en)
JPS4892839U (en)
JPS4892678A (en)
JPS4989851U (en)
CH590295A5 (en)
CH580913A5 (en)